Home

Insights

PE

Colinz Laboratories Ltd P/E Ratio

Colinz Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

6.2 K

stocks traded

Last Updated time: 14 Jul 15:30 PM

Image

Colinz Laboratories Ltd

NSE: COLINZLABS

PE

69.9

Last updated : 14 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Colinz Laboratories Ltd is 69.9 as of 14 Jul 15:30 PM .a1#The P/E Ratio of Colinz Laboratories Ltd changed from 19.1 on March 2019 to 19.2 on March 2023 . This represents a CAGR of 0.10% over 5 years. a1#The Latest Trading Price of Colinz Laboratories Ltd is ₹ 74.1 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 35.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Colinz Laboratories Ltd changed from ₹ 2.98 crore on March 2019 to ₹ 16 crore on March 2023 . This represents a CAGR of 39.95% over 5 years. a1#The Revenue of Colinz Laboratories Ltd changed from ₹ 1.88 crore to ₹ 1.74 crore over 8 quarters. This represents a CAGR of -3.80% a1#The EBITDA of Colinz Laboratories Ltd changed from ₹ 0.19 crore to ₹ 0.23 crore over 8 quarters. This represents a CAGR of 10.02% a1#The Net Pr of Colinz Laboratories Ltd changed from ₹ 0.11 crore to ₹ 0.14 crore over 8 quarters. This represents a CAGR of 12.82% a1#The Dividend Payout of Colinz Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Colinz Laboratories Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Colinz Laboratories Ltd

Period
Mar '1919.1
Mar '2024.1
Mar '2112.9
Mar '2224.5
Mar '2319.2

Company Fundamentals for Colinz Laboratories Ltd

Market Cap

33 Cr

EPS

1.1

P/E Ratio (TTM) *

69.9

P/B Ratio (TTM) *

3.1

Day’s High

79.44

Day’s Low

73.28

DTE *

0.1

ROE *

5.4

52 Week High

84.4

52 Week Low

33.35

ROCE *

7.2

* All values are consolidated

Last Updated time: 14 Jul 15:30 PM

* All values are consolidated

Last Updated time: 14 Jul 15:30 PM

Image

Colinz Laboratories Ltd

NSE: COLINZLABS

PRICE

74.1

-3.03 (-3.93%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Colinz Laboratories Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Colinz Laboratories Ltd

Market Value

34

Asset Value

8

3.3 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Colinz Laboratories Ltd6933
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Colinz Laboratories Ltd

Earnings

0 Cr

69.9 X

PE Ratio

Market Cap

₹33.87Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

0 Cr

69.9 X

PE Ratio

Market Cap

₹33.87Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Colinz Laboratories Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Colinz Laboratories Ltd

Period
Mar '193
Mar '204
Mar '213
Mar '2211
Mar '2316

* All values are a in crore

×

Historical Revenue of Colinz Laboratories Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Colinz Laboratories Ltd

Period
Jun '222
Sep '222
Dec '222
Mar '232
Jun '232
Sep '232
Dec '232
Mar '242

* All values are a in crore

×

Historical EBITDA of Colinz Laboratories Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Colinz Laboratories Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Net Profit of Colinz Laboratories Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Colinz Laboratories Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Dividend Payout of Colinz Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Colinz Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Colinz Laboratories Ltd

About Colinz Laboratories Ltd

    Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995. The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc. The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc. Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation. Apart from this, the Company has a WHO compliant plant at Sinnar. Apart from a modern plant, it has its own well equipped quality control laboratory. The technical team is headed by a Vice President (works), Plant Manager & Production Manager etc. They are highly qualified and FDA approved expert staff with over two decades of experience in manufacturing and development of a number of products for various therapeutic segments. The Company's products are enjoying a good Brand image, particularly among gynaecologists. The Company has potential to grow considering the fact that it is yet to open up its marketing operations in many states of the country, which is kept on hold due to general economic situation.

Colinz Laboratories Ltd News Hub

News

Colinz Laboratories to conduct board meeting

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 29 May...

Read more

04 May 202411:03

News

Colinz Laboratories to discuss results

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 31 Oct...

Read more

14 Oct 202320:35

News

Colinz Laboratories AGM scheduled

Colinz Laboratories announced that the 37th Annual General Meeting (AGM) of the company wi...

Read more

01 Aug 202314:20

News

Colinz Laboratories to declare Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 31 Jul...

Read more

14 Jul 202313:51

News

Colinz Laboratories to declare Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 27 May...

Read more

04 May 202311:36

News

Colinz Laboratories to declare Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 28 Jan...

Read more

12 Jan 202317:01

Product Composition by Percentage (Revenue)

FAQs for PE of Colinz Laboratories Ltd

What is Colinz Laboratories Ltd current share price?

The current market price of Colinz Laboratories Ltd as of July 14, 2024 is ₹74.10.

What is Colinz Laboratories Ltd's market cap?

Colinz Laboratories Ltd's market capitalisation stood at ₹33 Cr as of July 14, 2024

What are Colinz Laboratories Ltd's total net assets?

According to Colinz Laboratories Ltd's most recent financial filings, the company's net assets total ₹7.8 Cr.

Is Colinz Laboratories Ltd making a profit or loss?

Colinz Laboratories Ltd's net Profit as of July 14, 2024 is close to ₹0 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199